Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

October 8, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Plasmodium immunotherapy against Cancer

The unconventional pathway of DNA double-strand break repair

The inevitable Coronavirus third wave in India!

Plasmodium immunotherapy against Cancer
  • BiotechToday
  • World

Plasmodium immunotherapy against Cancer

BioTech Today July 16, 2021July 16, 2021

Aqsa, Jamia Millia Islamia

Cancer is a disease in which cells of the body grow abnormally and uncontrollably. Until now, there is still no permanent cure for cancer, but getting treatment for cancer might allow you to live for a certain period. Research for the cure of cancer has been underway for about 100 years now. There are different types of therapies available against cancer. These include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, stem cell or bone marrow transplant, and hormone therapy. Among these, immunotherapy is considered the leading one without any side effects.

A New Therapy:

There are different types of therapies available against cancer. These include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, stem cell or bone marrow transplant, and hormone therapy. Among these, immunotherapy is considered the leading one without any side effects. In cancer, the tumor secretes certain chemicals that inhibit the immune response, and immunotherapy works by uplifting these breaks, creating an immune response. T cells are the main force that fights against cancer.

The T-cells from a cancer patient express more checkpoint molecules, such as PD-1, and the cancer cells express the inhibitory ligands (such as PD-L1) of checkpoints. When activated T cells come in contact with cancer cells with inhibitory ligands, they become inactive, resulting in the escape of cancer cells. Recent studies have shown that infection with the Plasmodium parasite can also help in activating the inhibited immune system. Trials of Plasmodium immunotherapy for advanced lung cancer, breast and liver cancers, and advanced cancers have been approved and are ongoing in China.

Plasmodium immunotherapy:

There are two types of tumors: cold and hot tumors. Hot tumors remain surrounded by molecules that allow T cells to attack and kill the tumor cells. On the other hand, cold tumors remain surrounded by cells that can suppress the immune response and keep T cells from attacking the tumor cells and killing them. Cold tumors usually do not respond to immunotherapy. A method to switch cold tumors to hot tumors is by inducing Th1/proinflammatory cytokine response. Studies have shown that Plasmodium infection promotes Th1/proinflammatory cytokine production that activates innate immune cells such as Natural Killer cells and dendritic cells.

Natural killer cells and dendritic cells kill the cancer cells that would release tumor antigens. These antigens activate the tumor antigen-specific T cell responses and promote the killing of cancer cells. Plasmodium infection also increases the expression levels of co-stimulatory and co-inhibitory checkpoint molecules on CD8+ T cells. It also inhibits tumor angiogenesis and induces fever in humans that may also affect cancer cells. Plasmodium parasites can also act as a vaccine vector to construct a therapeutic cancer vaccine that could induce tumor antigen-specific T-cell responses. 

Significance of the study:

Plasmodium infection activates the whole immune system, which has been suppressed by a tumor. The mechanism of inhibition by Plasmodium makes it a suitable candidate for cancer immunotherapy to overcome the weakness of single targeted therapies. Single targeted therapies such as checkpoint blockade therapy may be ineffective for cold tumors and may induce acquired drug resistance of hot tumors.

Also read: Toolbox for flavor compound mapping in Mint

References:

  • Chen, X., Qin, L., Hu, W., & Adah, D. (2021). The mechanisms of action of Plasmodium infection against cancer. Cell Communication and Signaling, 19(1), 74. https://doi.org/10.1186/s12964-021-00748-5
  • Is there a cure for cancer? (n.d.). WebMD. Retrieved 13 July 2021, from https://www.webmd.com/cancer/guide/cure-for-cancer
  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged cancer immune response immune system Immunotherapy plasmodium Plasmodium immunotherapy T cells tumor tumour

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • India

The inevitable Coronavirus third wave in India!

BioTech Today July 16, 2021

Shenade Annie Kerketta, Amity University Kolkata The Indian Medical Association (IMA) has said “Opening up these rituals and enabling people without vaccination to go scot-free in these mass gatherings are potential super spreaders for the Covid third wave”. Thus, making the coronavirus third wave an inevitable event. Current statistics: Right now, the largest vaccination drive […]

Covid third wave

Related Post

  • BiotechToday
  • World

Human Brain Evolution Making ‘em Unique From Other Apes

bioxone December 22, 2020December 22, 2020

PRAGYA SANTRA, AMITY UNIVERSITY KOLKATA The protein-coding genomes for humans and chimpanzees are remarkably similar with a 1% difference. The biological feature that makes us unique and separable from chimpanzees is an intensely debated and interesting line of research.  According to the hypothesis, the researchers claim that it wasn’t so much DNA sequence but the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Sound-light pulse in 2D materials for the first time

BioTech Today June 18, 2021June 17, 2021

Koustav Maiti, Ramakrishna Mission Vivekananda Centenary College, Rahara Scientists from Technion – Israel Institute of Technology found evidence of the first-ever Sound-light pulse in 2D materials, i.e. the propagation of combined sound and light waves. It was done by using an ultrafast transmission electron microscope (UTEM)  in atomically thin materials. These experiments were conducted on […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

The unconventional pathway of DNA double-strand break repair

BioTech Today July 16, 2021July 15, 2021

Avani Dave, Jai Hind College Breast cancer gene BRCA1 has marked its presence as a protein mostly known for being an active contributor in the hereditary associated breast cancer. Apart from being the villain, BRCA1 also plays an indispensable role in the cellular machinery that works towards repairing the double-strand DNA breakage. Recently, researchers from […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy